US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

The findings, led by researchers from the Institute of Modern Physics (IMP) of the Chinese Academy of Sciences and their ...

Each time a new wonder drug or superfood pops on the market, I’m skeptical. That didn’t keep me from ordering a certain brand ...

A recent study has provided deeper insights into the microscopic mechanism behind heavy-ion cancer therapy, paving the way ...

Among 5602 participants assessed at the start of the first year of the study, the seroprevalence of IgG as assessed with ELISA was 42.8% (95% CI, 35.8 to 50.2). IgG seropositivity at the beginning ...

The immune molecule TGFβ has been found to weaken immune defences against latent viruses, triggering reactivation of the Epstein–Barr virus. This mechanism links TGFβ release in SARS-CoV-2 ...

This paper presents the important finding that BNIP3/NIX, a mitophagy receptor, and its binding to ATG18 are required for mitophagy during muscle cell reorganization in Drosophila. Although the ...